中医药信息
中醫藥信息
중의약신식
Information on Traditional Chinese Medicine
2015年
6期
71-73
,共3页
柴芩利胆汤%慢性胆囊炎%临床疗效%安全性
柴芩利膽湯%慢性膽囊炎%臨床療效%安全性
시금리담탕%만성담낭염%림상료효%안전성
Chaiqin Lidan deconction%Chronic cholecystitis%Clinically curative effect%Safety
目的:对中西医结合治疗慢性胆囊炎的临床疗效和安全性进行观察.方法:选取符合纳入标准的136例慢性胆囊炎患者,按照随机数字法随机分为观察组和对照组,每组68例,对照组采用常规西药治疗,观察组在对照组基础上给予柴芩利胆汤进行加减治疗,观察两组患者的临床疗效和安全性.结果:治疗后两组患者左上腹疼痛、腹胀、食欲不振、恶心、呕吐、胆囊区压痛发生率均显著降低(x2≥6.639,P均<0.05),但观察组左上腹疼痛、腹胀、食欲不振、恶心、呕吐、胆囊区压痛发生率下降更为明显(x2 =13.779、8.382、8.815、4.567、5.647,P均<0.05).两组患者治疗3个疗程后,观察组总有效率为97.0%显著性高于对照组的70.6%,差异具有统计学意义(x2 =17.568,P<0.01).两组治疗期间均未出现严重的不良反应;观察组出现皮疹6 例,发生率为8.8%,对照组出现皮疹7 例,发生率为10.3%,两组不良反应比较无显著性差异(x2 =0.085,P>0.05).结论:中西医结合治疗慢性胆囊炎含合并胆囊结石,标本兼治,其临床疗效要高于单纯西药的治疗效果.
目的:對中西醫結閤治療慢性膽囊炎的臨床療效和安全性進行觀察.方法:選取符閤納入標準的136例慢性膽囊炎患者,按照隨機數字法隨機分為觀察組和對照組,每組68例,對照組採用常規西藥治療,觀察組在對照組基礎上給予柴芩利膽湯進行加減治療,觀察兩組患者的臨床療效和安全性.結果:治療後兩組患者左上腹疼痛、腹脹、食欲不振、噁心、嘔吐、膽囊區壓痛髮生率均顯著降低(x2≥6.639,P均<0.05),但觀察組左上腹疼痛、腹脹、食欲不振、噁心、嘔吐、膽囊區壓痛髮生率下降更為明顯(x2 =13.779、8.382、8.815、4.567、5.647,P均<0.05).兩組患者治療3箇療程後,觀察組總有效率為97.0%顯著性高于對照組的70.6%,差異具有統計學意義(x2 =17.568,P<0.01).兩組治療期間均未齣現嚴重的不良反應;觀察組齣現皮疹6 例,髮生率為8.8%,對照組齣現皮疹7 例,髮生率為10.3%,兩組不良反應比較無顯著性差異(x2 =0.085,P>0.05).結論:中西醫結閤治療慢性膽囊炎含閤併膽囊結石,標本兼治,其臨床療效要高于單純西藥的治療效果.
목적:대중서의결합치료만성담낭염적림상료효화안전성진행관찰.방법:선취부합납입표준적136례만성담낭염환자,안조수궤수자법수궤분위관찰조화대조조,매조68례,대조조채용상규서약치료,관찰조재대조조기출상급여시금리담탕진행가감치료,관찰량조환자적림상료효화안전성.결과:치료후량조환자좌상복동통、복창、식욕불진、악심、구토、담낭구압통발생솔균현저강저(x2≥6.639,P균<0.05),단관찰조좌상복동통、복창、식욕불진、악심、구토、담낭구압통발생솔하강경위명현(x2 =13.779、8.382、8.815、4.567、5.647,P균<0.05).량조환자치료3개료정후,관찰조총유효솔위97.0%현저성고우대조조적70.6%,차이구유통계학의의(x2 =17.568,P<0.01).량조치료기간균미출현엄중적불량반응;관찰조출현피진6 례,발생솔위8.8%,대조조출현피진7 례,발생솔위10.3%,량조불량반응비교무현저성차이(x2 =0.085,P>0.05).결론:중서의결합치료만성담낭염함합병담낭결석,표본겸치,기림상료효요고우단순서약적치료효과.
Objective:To observe the curative effect and clinical safety of using integrative medicine for treating patients with chronic cholecystitis.Methods:136 cases of patients with chronic cholecystitis were selected and divided into an observation group and a control group (68 cases in each group) according to the random num-ber method.The control group received the conventional western medicine treatment, while the observation group was given Chaiqin Lidan decoction on the basis of the therapy in the control group.Clinical efficacy and clinical safety of two groups were recorded and compared.Results:In two groups after treatment incidences of left upper abdominal pain, abdominal distension, loss of appetite, nausea, vomiting and gallbladder area ten-derness were all significantly lower compared with those before treatment (χx2≥6.639,all P<0.05), but the incidences in the observation group were decreased more apparently (x2 =13.779, 8.382, 8.815,4.567 and 5.647, all P <0.05).After 3 courses of treatment, in the observation group the total effective rate was 97.0%,which was significantly higher than that of control group 70.6% (x2 =17.568,P<0.01).During treatment there was no severely adverse reaction in two groups;the observation group had 6 cases of erythra with the rate of 8.8%;while the control group had 7 cases of erythra with the rate of 10.3%, which had no significant difference (x2 =0.085,P>0.05) .Conclusion:Integrative medicine for treating chronic cholecysti-tis has a better curative effect, compared with only western medicine treatment.
